• Nintedanib (BIBF 1120): Precision Angiokinase Inhibition in

  2026-05-04

  Explore the advanced role of Nintedanib (BIBF 1120) as a triple angiokinase inhibitor in cancer research. This article uniquely unpacks mechanistic insights and practical considerations for biomarker-driven applications, grounded in recent high-grade glioma findings.

• Reactive Oxygen Species Assay Kit: Precision ROS Detection i

  2026-05-04

  Unlock quantitative oxidative stress analysis in live cells with the APExBIO Reactive Oxygen Species Assay Kit. This guide delivers workflow upgrades, troubleshooting insights, and direct translation of advanced cancer research findings into actionable assay protocols.

• Starvation, ER-Ca2+-Calpain Axis, and Cell Fate in Bombyx mo

  2026-05-03

  This study reveals how prolonged starvation in Bombyx mori induces a switch from autophagy to apoptosis in fat body tissue via the ER-Ca2+-calpain signaling axis. By dissecting calcium dynamics and the role of IP3R inhibition, the research clarifies mechanisms of programmed cell death under nutritional stress and highlights 2-APB’s utility in pathway interrogation.

• Prestained Protein Marker: Triple Color Ladder for Reliable

  2026-05-02

  The Prestained Protein Marker (Triple color, EDTA free, 10-250 kDa) from APExBIO offers unmatched visibility, Phosbind compatibility, and streamlined workflows for SDS-PAGE and Western blotting. Its tri-color format and ready-to-use formulation empower researchers to achieve reproducible molecular weight determination and robust protein transfer assessment, even in advanced fluorescent imaging scenarios.

• Sex-Biased Gene Expression in Neural Differentiation of hESC

  2026-05-01

  This study delivers the first comprehensive analysis of sex-biased gene expression during neural differentiation in multiple human embryonic stem cell (hESC) lines. It demonstrates that genetic sex differences, independent of hormonal effects, shape neuronal developmental trajectories, revealing key candidate genes and implications for neurodevelopmental research.

• Polymyxin B Sulfate: Advanced Workflows in Immunity & Infect

  2026-05-01

  Polymyxin B (sulfate) from APExBIO uniquely bridges bactericidal power with immunomodulatory finesse—empowering both infection control and advanced immune modeling. This article details optimized protocols, troubleshooting, and the latest translational insights for maximizing assay reproducibility in multidrug-resistant Gram-negative research.

• Reactive Oxygen Species Assay Kit: Advanced Insights for Pre

  2026-04-30

  Explore the science and new applications of the Reactive Oxygen Species Assay Kit using the DCFH-DA fluorescent probe. This article uniquely bridges molecular mechanisms with translational research needs, empowering oxidative stress measurement assay design.

• RCN2 Drives ESCC Metastasis and Cisplatin Resistance via PI3

  2026-04-30

  This study reveals that reticulocalbin 2 (RCN2) promotes metastasis and cisplatin resistance in esophageal squamous cell carcinoma (ESCC) by enabling UBR5-mediated degradation of PPP2CA, leading to PI3K-AKT pathway activation. The findings provide mechanistic insight into ESCC progression and highlight RCN2 as a potential therapeutic target for overcoming treatment resistance.

• Polymyxin B Sulfate: Advanced Workflows in Infection Researc

  2026-04-29

  Polymyxin B (sulfate) from APExBIO empowers researchers to tackle multidrug-resistant Gram-negative bacteria and probe immune modulation with confidence. This guide offers workflow enhancements, troubleshooting strategies, and actionable protocol parameters—bridging reference-backed findings with practical laboratory execution.

• Resiniferatoxin (RTX): Precision TRPV1 Silencing in Analgesi

  2026-04-29

  Resiniferatoxin (RTX) delivers ultra-potent, targeted inactivation of TRPV1-positive sensory neurons, enabling long-lasting and reproducible analgesia in preclinical and emerging clinical applications. This guide translates the latest mechanistic insights and protocol advances into actionable workflows, troubleshooting approaches, and unique benefits for pain research.

• Bazedoxifene Targets IL-6/GP130 Signaling for Cancer Therapy

  2026-04-28

  Shi et al. (2024) review the repositioning of bazedoxifene (BZA), an FDA-approved SERM, as an inhibitor of the IL-6/GP130 pathway implicated in cancer progression. The study highlights BZA’s novel mechanism of disrupting pro-tumorigenic signaling, offering new avenues for targeted therapy and combinatorial strategies in oncology.

• Tolazoline in Translational Research: Mechanism, Models, and

  2026-04-28

  This thought-leadership article delivers a mechanistic and strategic perspective on Tolazoline, an α2-adrenergic receptor antagonist, for translational researchers. It integrates the latest evidence on neuroendocrine and airway smooth muscle modulation, guides protocol design, appraises competitive alternatives, and positions APExBIO’s Tolazoline as a critical tool for pioneering islet and airway studies. Expanding beyond routine product summaries, this piece bridges current literature with future translational opportunities, including the relevance of insulin signaling pathways in neurodegenerative disease models.

• Reelin-SFK Pathway: A Crucial Permissive Factor for Ketamine

  2026-04-27

  This study demonstrates that intact synaptic Reelin signaling via Apoer2 and Src family kinases is indispensable for ketamine-induced synaptic and behavioral antidepressant effects in mice. The findings clarify a molecular mechanism underlying nonresponsiveness to ketamine and provide a framework for further research into synaptic signaling in neuropsychiatric disorders.

• Super-Enhancer Hijacking of LINC01977 Drives Early LUAD by T

  2026-04-27

  Zhang et al. uncover that super-enhancer (SE) hijacking of the lncRNA LINC01977 promotes malignancy in early-stage lung adenocarcinoma (LUAD) through a canonical TGF-β/Smad3-dependent pathway. This study defines a novel feedback loop involving tumor-associated macrophages and identifies LINC01977 as a potential therapeutic target for early intervention in LUAD progression.

• Bufalin as a Cardiotoic Steroid: Optimizing Apoptosis in TNB

  2026-04-26

  Bufalin, a cardiotonic steroid from APExBIO, is redefining apoptosis induction and molecular target degradation in triple-negative breast cancer (TNBC) and hepatocellular carcinoma research. This deep dive connects the latest mechanistic evidence with practical workflows, protocol parameters, and hands-on troubleshooting tips to maximize reproducibility and insight in oncology labs.

15237 records 4/1016 page Previous Next 12345 下5页 Last page